Phase II Human Trial of ViralClear's Anti-Viral for SARS-CoV-2 Coronavirus Underway at 4 Key Trial...
GlobeNewswire via Yahoo Finance· 17 hours agoNasdaq: BSGM) ("BioSig" or the "Company") and its subsidiary, ViralClear Pharmaceuticals, Inc. today announced the enrollment of adult patients for its Phase II trial for ...
Hedge Funds Bullish On Points International Ltd (PCOM)
Insider Monkey via Yahoo Finance· 6 days agoInsider Monkey has processed numerous 13F filings of hedge funds and successful value investors to...
Antivirals In The COVID-19 Space
Seeking Alpha· 12 hours agoAfter my earlier article, I thought I’d endorse my belief that antiviral combination therapy rather than vaccines will be the way to manage the COVID-19 pandemic. Recently, an FDA vaccine official ...
ViralClear Pharmaceuticals Partners with Albany Molecular Research
citybizlist Boston· 2 days agoWestport, CT, July 08, 2020 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (Nasdaq: BSGM) and its subsidiary, ViralClear Pharmaceuticals, Inc., today announced that it is partnering with Albany Molecular Research
Antivirals Rather Than Vaccines For COVID-19 (NASDAQ:BCRX)
Seeking Alpha· 7 days agoWill an anti-COVID-19 vaccine be effective? Much has been written about the potential of multiple vaccines to ultimately prevent COVID-19, the condition caused by the SARS-CoV-2 coronavirus.
